Covid-19: Vaccinations and Global Public Health — House of Lords, 2021-09-09
Topic: Health
Sarah Virginia Brinton (Liberal Democrats, Centre to centre-left): My Lords, I congratulate the noble Lord, Lord Boateng, on securing this important debate, and I agree with every word that he said in his compelling contribution I am also grateful to the Association of the British Pharmaceutical Industry for its briefing, updating us on the substantial increase in manufacturing capacity for Covid vaccines. It is worth starting by noting the extraordinary work of our vaccine experts globally, from scientists such as Sarah Gilbert and her team who were working in January 2020, through to the manufacturing companies that have made the most extraordinary steps to provide over 5 billion doses of vaccine to date worldwide, with 41% of the world’s population having had at least one dose. But—and this is the reason for the noble Lord’s important debate today—shockingly, only 1.9% of people in low-income countries have had one dose to date The role of Gavi and the World Health Organization in encouraging high-income countries to share doses as soon as possible has been laudable, and those countries, including the UK, that have guaranteed funding to Gavi are also vital. Credit goes to our Government for stepping up to the plate early with those offers. The comments from the noble Lord, Lord Boateng, about the theory of COVAX versus the actual practical attitude of G7 countries were blunt and right, however Much money has been made available to Gavi for COVAX. The practical problem of sourcing new vaccine manufacturing has proved understandably difficult. That is why the World Health Organization has repeatedly asked high-income countries to donate substantial numbers of doses to low-income countries. We on these Benches urged the Prime Minister to set an example from the United Kingdom in his role as the chair of the G7, but sadly he did not. All that was repeated was the amount of money given to Gavi, which was no use when there was no manufacturing availability. The figure of a 1.9% rate of vaccination in low-income countries is testament to that The World Health Organization has rightly said that "none of us will be safe until everyone is safe." That is about overall safety, not just for all people in all countries, but also about the mitigations that we in the UK need to take in our own communities to keep transmission down. I am sorry to say that we are not doing that here in England. This Government have removed all mitigations and that is one of the reasons they are pushing for so many people to have booster jabs—way beyond what is really necessary at the moment. The clinically extremely vulnerable, of whom I am one, are staying at home under the government guidance because we should not be mixing with unvaccinated people. But we must make sure that those who can manage and make changes in their lives—face masks, social distancing and ensuring that spaces they enter are ventilated—play their part as well as government I have been watching what has been happening in America. The difference in the numbers of cases, hospitalisations and deaths between states where there are mask mandates and other mitigations and those where there are defiantly no mitigations is truly shocking. Many countries in the global south do not have the resources to provide even these mitigations However, there is hope. This month, Covid-19 vaccine manufacturing output will pass the 7.5 billion dose mark, with manufacturers worldwide now producing 1.5 billion doses per month and further continued growth is expected. If there are no major bottlenecks, by June of next year total vaccine production is estimated to reach over 24 billion, by which time vaccine supplies will most likely outstrip global demand This is subject, of course, to the emergence of any new variant that is resistant to the currently approved vaccines. There is recent news of the mu variant, which appears to be resistant to the Pfizer vaccine, and worldwide experts are monitoring that and all new variants continuously. We may be relying on our pharmaceutical industry to produce new vaccines for whatever threats are coming down the line. The good news is that G7 countries have sufficient stocks of vaccine doses to vaccinate their own adults and teenagers, and to roll out booster programmes to protect the most at-risk groups—as well as substantially increase the number of doses available to lower and lower-middle-income countries There are various things that need to be done, though, and the UK must take the lead on this while we chair the G7. These include stepping up dose sharing, continuing to optimise production, calling for the trade barriers that the noble Lord, Lord Boateng, spoke about to be eliminated, supporting country readiness and driving further innovation. I ask the Minister: what is the current number of doses to be donated from the UK between now and the end of this calendar year? How much will be donated next year? While we chair the G7, it is vital that we lead the way and donate as many doses as we can as soon as we can.